Showing results (31-40 of 1,749) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 30, 2016
Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune DiseaseLara V Maul, Michael Weichenthal, Katharina C Kähler, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2016
Combined Cancer Immunotherapy Against Aurora Kinase AIva Kaštánková, Ingrid Poláková, Martina Dušková, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 25, 2022
A Retrospective Study of Ipilimumab Plus Nivolumab in Anti-PD-L1/PD-1 Refractory Merkel Cell CarcinomaSophia Z Shalhout, Kevin S Emerick, Howard L Kaufman, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2017
Ubiquitinated Proteins Isolated From Tumor Cells Are Efficient Substrates for Antigen Cross-PresentationGuangjie Yu, Tarsem Moudgil, Zhihua Cui, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2017
DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft RejectionJanin Chandra, Julie L Dutton, Bo Li, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2017
Vogt-Koyanagi-Harada-like Syndrome Complicating Pembrolizumab Treatment for Metastatic MelanomaMarion Bricout, Adeline Petre, Mona Amini-Adle, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 19, 2019
Improving Immunotherapy Against B-Cell Malignancies Using γδ T-Cell-specific Stimulation and Therapeutic Monoclonal AntibodiesTimm Hoeres, Dominik Pretscher, Elisabeth Holzmann, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 19, 2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With GlioblastomaStephanie L Goff, Richard A Morgan, James C Yang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2019
Chimeric Antigen Receptor-modified Donor Lymphocyte Infusion Improves the Survival of Acute Lymphoblastic Leukemia Patients With Relapsed Diseases After Allogeneic Hematopoietic Stem Cell TransplantationTao Wang, Lei Gao, Xiaoxia Hu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2019
Activated Allogeneic Donor-derived Marrow-infiltrating Lymphocytes Display Measurable In Vitro Antitumor ActivityLuca Biavati, Kimberly Noonan, Leo Luznik, et al.Pageof 175